Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 1, 2000, Pages 119-121

  Stoiser, B ^a   Thalhammer, F ^a   El Menyawi, I ^a   Wilfing, A ^a   Daxbock F ^a   Locker, G J ^a   Burgmann, H ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HOMOCYSTEINE; INTERLEUKIN 6; LAMININ;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK; TREATMENT OUTCOME;

EID: 0033967840     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.7.1.119-121.2000     Document Type: Article

References (17)

1. Bellamy, M. F., and I. F. McDowell. 1997. Putative mechanisms for vascular damage by homocysteine. J. Inherit. Metab. Dis. 20:307-315.
2. Boers, G. H., A. G. Smals, F. J. Trijbels, B. Fowler, J. A. Bakkeren, H. C. Schoonderwaldt, W. J. Kleijer, and P. W. Kloppenborg. 1985. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313:709-715.
3. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655.
4. Burgmann, H., U. Hollenstein, T. Maca, K. Zedwitz Liebenstein, F. Thalhammer, R. Koppensteiner, H. Ehringer, and W. Graninger. 1996. Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. J. Clin. Pathol. 49:508-510.
5. De Groote, G. M., T. Testerman, Y. Xu, G. Stauffer, and F. C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414-417.
6. El Menyawi, I., S. Looareesuwan, S. Knapp, F. Thalhammer, B. Stoiser, and H. Burgmann. 1998. Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl. 706:347-351.
7. Gressner, A. M., and W. Tittor. 1986. Serum laminin - its concentration increases with portal hypertension in cirrhotic liver disease. Klin. Wochenschr. 64:1240-1248.
8. Guseva, N. G., N. V. Anikina, R. Myllyla, L. Risteli, J. Risteli, J. V. Chochlova, K. I. Kivirikko, and V. A. Nassonova. 1991. Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis. Ann. Rheum. Dis. 50:481-486.
9. Kahaleh, M. B. 1990. Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions. Rheum. Dis. Clin. N. Am. 16:53-73.
10. Moutabarrik, A., I. Nakanishi, D. Zaid, M. Namiki, N. Kawaguchi, S. Onishi, M. Ishibashi, and A. Okuyama. 1994. Interleukin-1-beta activation of cultured glomerular epithelial cells. Exp. Nephrol. 2:196-204.
11. Nicolaou, A., S. H. Kenyon, J. M. Gibbons, T. Ast, and W. A. Gibbons. 1996. In vitro inactivation of mammalian methionine synthase by nitric oxide. Eur. J. Clin. Investig. 26:167-170.
12. Rochlitz, C., C. Hasslacher, D. G. Brocks, and R. Hermann. 1987. Serum concentration of laminin, and course of the disease in patients with various malignancies. J. Clin. Oncol. 5:1424-1429.
13. Segarra, A., L. L. Masmiquel, R. Simo, R. M. Segura, R. Sauri, and L. L. Piera. 1996. Which factors account for increased serum laminin levels in patients with chronic renal diseases. Nephron 72:359-360.
14. Timpl, R., H. Rohde, P. G. Robey, S. I. Rennard, J. M. Foidart, and G. R. Martin. 1979. Laminin - a glycoprotein from basement membranes. J. Biol. Chem. 254:9933-9937.
15. Upchurch-GR, J., G. N. Welch, A. J. Fabian, A. Pigazzi, J. Keaney-JF, and J. Loscalzo. 1997. Stimulation of endothelial nitric oxide production by homocyst(e)ine. Atherosclerosis 132:177-185.
16. Wenisch, C., D. Myskiw, E. Narzt, E. Presterl, and W. Graninger. 1995. Laminin in Graves' disease. Eur. J. Clin. Investig. 25:425-428.
17. Zimmerman, J. E., D. P. Wagner, W. A. Knaus, J. F. Williams, D. Kolakowski, and E. A. Draper. 1995. The use of risk predictions to identify candidates for intermediate care units. Chest 108:490-499.